Skip to content

Author

T. M. Aljarba

We have 2 of 56 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Jul 2026

Structure-Based identification of potent dengue virus RNA-dependent RNA polymerase inhibitors using integrated computational workflow

An integrated computational workflow was applied to identify potential inhibitors of dengue virus RNA-dependent RNA polymerase (RdRp) after screening of approximately 9,900 bioactive compounds through structure-based virtual screening and molecular docking, supporting these compounds as promising RdRp inhibitors.

T. M. Aljarba, A. Alam, Gopal Prasad Agrawal et al. · 0 citations
Open access Jul 2026

Greenness, blueness, and whiteness profiles of HPTLC method for the simultaneous assay of tenofovir and emtricitabine in fixed-dose combination dosage forms

A sustainable reverse-phase HPTLC methodology for determining TEN and ECT concurrently in their fixed-dose combination (FDC) products is developed and verifies and suggested that the recommended method may be applied to precisely evaluate TEN and ECT in commercial formulations.

P. Alam, Faiyaz Shakeel, M. Alqarni et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.